Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1475-2840-9-5.

Title:
Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat | Cardiovascular Diabetology
Description:
Background Diabetes is associated with changes in myocardial stress-response pathways and is recognized as an independent risk factor for cardiac remodeling. Using spontaneously diabetic Goto Kakizaki rats as a model of type 2 DM we investigated whether post-translational modifications in the Akt - FOXO3a pathway, Sirt1 - p53 pathway and the mitogen activated protein kinase p38 regulator are involved in post-infarct cardiac remodeling Methods Experimental myocardial infarction (MI) was induced by left anterior descending coronary artery ligation in spontaneously diabetic Goto-Kakizaki rats and non-diabetic Wistar controls. Cardiac function was studied by echocardiography. Myocardial hypertrophy, cardiomyocyte apoptosis and cardiac fibrosis were determined histologically 12 weeks post MI or Sham operation. Western blotting was used to study Caspase-3, Bax, Sirt1, acetylation of p53 and phosphorylation of p38, Akt and FOXO3a. Electrophoretic mobility shift assay was used to assess FOXO3a activity and its nuclear localization. Results Post-infarct heart failure in diabetic GK rats was associated with pronounced cardiomyocyte hypertrophy, increased interstitial fibrosis and sustained cardiomyocyte apoptosis as compared with their non-diabetic Wistar controls. In the GK rat myocardium, Akt- and FOXO3a-phosphorylation was decreased and nuclear localization of FOXO3a was increased concomitantly with increased PTEN protein expression. Furthermore, increased Sirt1 protein expression was associated with decreased p53 acetylation, and phosphorylation of p38 was increased in diabetic rats with MI. Conclusions Post-infarct heart failure in diabetic GK rats was associated with more pronounced cardiac hypertrophy, interstitial fibrosis and sustained cardiomyocyte apoptosis as compared to their non-diabetic controls. The present study suggests important roles for Akt-FOXO3a, Sirt1 - p53 and p38 MAPK in the regulation of post-infarct cardiac remodeling in type 2 diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

rats, article, pubmed, diabetic, wistar, google, scholar, protein, apoptosis, cardiac, myocardial, cardiomyocyte, increase, cas, heart, increased, expression, figure, hypertrophy, sirt, area, rat, foxoa, akt, study, remodeling, diabetes, phosphorylation, tissue, left, postinfarct, showed, gotokakizaki, infarct, shows, infarction, fibrosis, shamoperated, remote, kinase, weeks, results, size, ventricular, factor, nondiabetic, western, mapk, cell, shown,

Topics {✒️}

atrial natriuretic peptide chico/pi3-kinase signaling pathway short axis view rabbit anti-digoxigenin-ap-conjugate sham-operated goto-kakizaki rats spontaneously diabetic goto-kakizaki open access article diabetic goto-kakizaki rat ville kytö goto-kakizaki rat heart digoxigenin-conjugated dideoxy-utp diabetic goto-kakizaki rats article download pdf post-infarct cardiac remodeling representative m-mode echocardiography sirt1-positive cardiomyocytes/total number shows picrosirius--red stained cardiac p38-mapk pathway mi-induced cardiomyocyte hypertrophy diabetes-induced cardiac hypertrophy author information authors post-infarct gk rats m-mode lv dimensions mi-induced cardiac remodeling improves cardiac function trichrome-stained histological sections akt-mediated phosphorylation foxo3a post-infarct wistar rats accelerate cardiomyocyte growth diabetic goto-kakizaki basic biochemical parameters angiotensin ii-induced inflammation formalin-fixed myocardial sections digoxigenin antibody conjugated lv end-diastolic volume lv end-systolic volume post--mi gk rats post-mi gk rats increased nuclear foxo3a-translocation goto-kakizaki rats sirt1-target protein p53 foxo3a transcription factor digoxigenin-tagged foxo3a oligonucleotides long-term activation anti-phospho-fkhrl/foxo3a foxo3a-regulated target genes methods myocardial infarction post-mi wistar rats forkhead transcription factor increased cardiomyocyte hypertrophy

Questions {❓}

  • O'Neill BT, Abel ED: Akt1 in the cardiovascular system: friend of foe?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat
         description:Diabetes is associated with changes in myocardial stress-response pathways and is recognized as an independent risk factor for cardiac remodeling. Using spontaneously diabetic Goto Kakizaki rats as a model of type 2 DM we investigated whether post-translational modifications in the Akt - FOXO3a pathway, Sirt1 - p53 pathway and the mitogen activated protein kinase p38 regulator are involved in post-infarct cardiac remodeling Experimental myocardial infarction (MI) was induced by left anterior descending coronary artery ligation in spontaneously diabetic Goto-Kakizaki rats and non-diabetic Wistar controls. Cardiac function was studied by echocardiography. Myocardial hypertrophy, cardiomyocyte apoptosis and cardiac fibrosis were determined histologically 12 weeks post MI or Sham operation. Western blotting was used to study Caspase-3, Bax, Sirt1, acetylation of p53 and phosphorylation of p38, Akt and FOXO3a. Electrophoretic mobility shift assay was used to assess FOXO3a activity and its nuclear localization. Post-infarct heart failure in diabetic GK rats was associated with pronounced cardiomyocyte hypertrophy, increased interstitial fibrosis and sustained cardiomyocyte apoptosis as compared with their non-diabetic Wistar controls. In the GK rat myocardium, Akt- and FOXO3a-phosphorylation was decreased and nuclear localization of FOXO3a was increased concomitantly with increased PTEN protein expression. Furthermore, increased Sirt1 protein expression was associated with decreased p53 acetylation, and phosphorylation of p38 was increased in diabetic rats with MI. Post-infarct heart failure in diabetic GK rats was associated with more pronounced cardiac hypertrophy, interstitial fibrosis and sustained cardiomyocyte apoptosis as compared to their non-diabetic controls. The present study suggests important roles for Akt-FOXO3a, Sirt1 - p53 and p38 MAPK in the regulation of post-infarct cardiac remodeling in type 2 diabetes.
         datePublished:2010-01-27T00:00:00Z
         dateModified:2010-01-27T00:00:00Z
         pageStart:1
         pageEnd:13
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1475-2840-9-5
         keywords:
            Atrial Natriuretic Peptide
            Connective Tissue Growth Factor
            Electrophoretic Mobility Shift Assay
            Cardiomyocyte Apoptosis
            Cardiomyocyte Hypertrophy
            Diabetes
            Angiology
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig7_HTML.jpg
         isPartOf:
            name:Cardiovascular Diabetology
            issn:
               1475-2840
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Erik Vahtola
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marjut Louhelainen
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanna Forstén
               affiliation:
                     name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
                     address:
                        name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Saara Merasto
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johanna Raivio
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Petri Kaheinen
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ville Kytö
               affiliation:
                     name:Turku University Hospital
                     address:
                        name:Department of Medicine, Turku University Hospital, Turku, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ilkka Tikkanen
               affiliation:
                     name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
                     address:
                        name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jouko Levijoki
               affiliation:
                     name:Orion Pharma Ltd
                     address:
                        name:Orion Pharma Ltd, Espoo, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eero Mervaala
               affiliation:
                     name:University of Helsinki
                     address:
                        name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat
      description:Diabetes is associated with changes in myocardial stress-response pathways and is recognized as an independent risk factor for cardiac remodeling. Using spontaneously diabetic Goto Kakizaki rats as a model of type 2 DM we investigated whether post-translational modifications in the Akt - FOXO3a pathway, Sirt1 - p53 pathway and the mitogen activated protein kinase p38 regulator are involved in post-infarct cardiac remodeling Experimental myocardial infarction (MI) was induced by left anterior descending coronary artery ligation in spontaneously diabetic Goto-Kakizaki rats and non-diabetic Wistar controls. Cardiac function was studied by echocardiography. Myocardial hypertrophy, cardiomyocyte apoptosis and cardiac fibrosis were determined histologically 12 weeks post MI or Sham operation. Western blotting was used to study Caspase-3, Bax, Sirt1, acetylation of p53 and phosphorylation of p38, Akt and FOXO3a. Electrophoretic mobility shift assay was used to assess FOXO3a activity and its nuclear localization. Post-infarct heart failure in diabetic GK rats was associated with pronounced cardiomyocyte hypertrophy, increased interstitial fibrosis and sustained cardiomyocyte apoptosis as compared with their non-diabetic Wistar controls. In the GK rat myocardium, Akt- and FOXO3a-phosphorylation was decreased and nuclear localization of FOXO3a was increased concomitantly with increased PTEN protein expression. Furthermore, increased Sirt1 protein expression was associated with decreased p53 acetylation, and phosphorylation of p38 was increased in diabetic rats with MI. Post-infarct heart failure in diabetic GK rats was associated with more pronounced cardiac hypertrophy, interstitial fibrosis and sustained cardiomyocyte apoptosis as compared to their non-diabetic controls. The present study suggests important roles for Akt-FOXO3a, Sirt1 - p53 and p38 MAPK in the regulation of post-infarct cardiac remodeling in type 2 diabetes.
      datePublished:2010-01-27T00:00:00Z
      dateModified:2010-01-27T00:00:00Z
      pageStart:1
      pageEnd:13
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1475-2840-9-5
      keywords:
         Atrial Natriuretic Peptide
         Connective Tissue Growth Factor
         Electrophoretic Mobility Shift Assay
         Cardiomyocyte Apoptosis
         Cardiomyocyte Hypertrophy
         Diabetes
         Angiology
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2840-9-5/MediaObjects/12933_2009_Article_224_Fig7_HTML.jpg
      isPartOf:
         name:Cardiovascular Diabetology
         issn:
            1475-2840
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Erik Vahtola
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marjut Louhelainen
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanna Forstén
            affiliation:
                  name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
                  address:
                     name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Saara Merasto
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johanna Raivio
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Petri Kaheinen
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ville Kytö
            affiliation:
                  name:Turku University Hospital
                  address:
                     name:Department of Medicine, Turku University Hospital, Turku, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ilkka Tikkanen
            affiliation:
                  name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
                  address:
                     name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jouko Levijoki
            affiliation:
                  name:Orion Pharma Ltd
                  address:
                     name:Orion Pharma Ltd, Espoo, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eero Mervaala
            affiliation:
                  name:University of Helsinki
                  address:
                     name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cardiovascular Diabetology
      issn:
         1475-2840
      volumeNumber:9
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
      name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
      address:
         name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
         type:PostalAddress
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
      name:Turku University Hospital
      address:
         name:Department of Medicine, Turku University Hospital, Turku, Finland
         type:PostalAddress
      name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
      address:
         name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
         type:PostalAddress
      name:Orion Pharma Ltd
      address:
         name:Orion Pharma Ltd, Espoo, Finland
         type:PostalAddress
      name:University of Helsinki
      address:
         name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Erik Vahtola
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Marjut Louhelainen
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Hanna Forstén
      affiliation:
            name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
            address:
               name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Saara Merasto
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Johanna Raivio
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Petri Kaheinen
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Ville Kytö
      affiliation:
            name:Turku University Hospital
            address:
               name:Department of Medicine, Turku University Hospital, Turku, Finland
               type:PostalAddress
            type:Organization
      name:Ilkka Tikkanen
      affiliation:
            name:Helsinki University Hospital, Finland and Minerva Institute for Medical Research
            address:
               name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
               type:PostalAddress
            type:Organization
      name:Jouko Levijoki
      affiliation:
            name:Orion Pharma Ltd
            address:
               name:Orion Pharma Ltd, Espoo, Finland
               type:PostalAddress
            type:Organization
      name:Eero Mervaala
      affiliation:
            name:University of Helsinki
            address:
               name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
      name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland
      name:Department of Medicine, Turku University Hospital, Turku, Finland
      name:Department of Medicine, Helsinki University Hospital, Finland and Minerva Institute for Medical Research, Helsinki, Finland
      name:Orion Pharma Ltd, Espoo, Finland
      name:Institute of Biomedicine, Pharmacology, University of Helsinki, Finland

External Links {🔗}(187)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📦}

  • Crossref

5.7s.